½ñÈÕ¶¯Ì¬ ·µ»ØÊ×Ò³
»áÔ±×¢²á µÇ¼ ÉúÎïͨ¿ìѶÃâ·Ñ¶©ÔÄ
  • Ê×Ò³ ½ñÈÕ¶¯Ì¬ È˲ÅÊг¡ Ð¼¼ÊõרÀ¸ Öйú¿ÆÑ§ÈË ÔÆÕ¹Ì¨
    BioHot
    • ¶¨ÖÆÎÒµÄBioHot
    • ½øÈëÎÒµÄBioHot
    • ½øÈëÎҵÉ
    • Ö×Áö°©Ö¢Ñо¿
    • ÃâÒß/»ùÒò/ϸ°ûÁÆ·¨
    • Éñ¾­ÉúÎïѧ
    • ½¡¿µÓë¼²²¡
    • Ë¥ÀÏ»úÖÆÓ볤ÊÙ
    • µ¥Ï¸°û¼¼Êõ
    • »ùÒò±à¼­-CRISPR
    • RNAÑо¿
    • ³¦µÀ¾úÓëÈËÌå΢Éú̬
    • ϸ°û´úл
    • AIÉúÎïÐÅϢѧ
    • COVID
    ÔÆ½²ÌÃÖ±²¥ »áÕ¹ÖÐÐÄ ÌØ¼ÛרÀ¸ ¼¼Êõ¿ìѶ Ãâ·ÑÊÔÓÃ

  • ÉúÎïͨ¹Ù΢
    ÅãÄãץסÉúÃü¿Æ¼¼
    Ìø¶¯µÄÂö²«

ÉúÎïͨÊ×Ò³  >  ½ñÈÕ¶¯Ì¬  >  ÕýÎÄ

Īɣ±È¿ËÉçÇøÉ¸²éµãÌṩCOVID-19×Ô²âµÄ¿ÉÐÐÐÔÓë¿É½ÓÊÜÐÔ£ºÒ»Ïî»ìºÏ·½·¨Ñо¿

¡¶BMC Public Health¡·£ºFeasibility and acceptability of COVID-19 self-testing offered through community screening posts in Mozambique: a mixed-methods study

¡¾×ÖÌ壺 ´ó ÖРС ¡¿ ʱ¼ä£º2026Äê03ÔÂ07ÈÕ À´Ô´£ºBMC Public Health 4.4

±à¼­ÍƼö£º

¡¡¡¡ÕªÒª±³¾°ÔÚµÍÊÕÈëºÍÖеÈÊÕÈë¹ú¼Ò£¬COVID-19×ÔÎÒ¼ì²âÊÇÓÃÓÚÏÖ³¡¼ì²â¼°ÒßÇé¹ÜÀíµÄÖØÒª²ßÂÔ£¬ÓÐÖúÓÚʶ±ð¸ÐȾSARS-CoV-2µÄÈË¡£ÎÒÃÇÑо¿ÁËÔÚĪɣ±È¿ËÄϲ¿³ÇÊм°³Ç½¼µØÇø¡¢Õë¶ÔCOVID-19ºÍ½áºË²¡µÄÉçÇøË«Ïòɸ²éµãÉÏ£¬ÓÉÒ½»¤ÈËÔ±¼à¶½ÏµÄCOVID-19×ÔÎÒ¼ì²âµÄ¿ÉÐÐÐԺͿɽÓÊÜÐÔ

¡¡¡¡

ÕªÒª

±³¾°

ÔÚµÍÊÕÈëºÍÖеÈÊÕÈë¹ú¼Ò£¬COVID-19×ÔÎÒ¼ì²âÊÇÓÃÓÚÏÖ³¡¼ì²â¼°ÒßÇé¹ÜÀíµÄÖØÒª²ßÂÔ£¬ÓÐÖúÓÚʶ±ð¸ÐȾSARS-CoV-2µÄÈË¡£ÎÒÃÇÑо¿ÁËÔÚĪɣ±È¿ËÄϲ¿³ÇÊм°³Ç½¼µØÇø¡¢Õë¶ÔCOVID-19ºÍ½áºË²¡µÄÉçÇøË«Ïòɸ²éµãÉÏ£¬ÓÉÒ½»¤ÈËÔ±¼à¶½ÏµÄCOVID-19×ÔÎÒ¼ì²âµÄ¿ÉÐÐÐԺͿɽÓÊÜÐÔ¡£

·½·¨

2023Äê5ÔÂÖÁ8ÔÂÆÚ¼ä£¬³öÏÖCOVID-19ÒÉËÆÖ¢×´µÄÈËȺÒÔ¼°ÓиÐȾ·çÏÕµÄÈËȺ¿É½øÐÐ×ÔÎÒ¼ì²â¡£ÎÒÃÇÊÕ¼¯ÁËÕâЩÍê³É×ÔÎÒ¼ì²âÕßµÄÏà¹Ø»¤ÀíÁ÷³ÌÊý¾ÝÓëµ÷²éÊý¾Ý£¬²¢Í¨¹ýÂß¼­»Ø¹é·ÖÎöÓ°ÏìËûÃÇÔÙ´ÎʹÓøÃ×ÔÎÒ¼ì²â¹¤¾ßµÄ¿ÉÄÜÐÔµÄÒòËØ¡£´ËÍ⣬ÎÒÃÇ»¹¶Ô²¿·Ö¼ì²âÕß¼°¼à¶½ËûÃǵÄÒ½»¤ÈËÔ±½øÐÐÁ˰ë½á¹¹»¯Éî¶È·Ã̸£¬½ø¶øÔËÓÃÖ÷Ìâ·ÖÎö·¨¶ÔÆä·Ã̸¼Ç¼½øÐнâ¶Á¡£

½á¹û

ÎÒÃǹ²ÑûÇë382È˽øÐÐ×ÔÎÒ¼ì²â£¬ÆäÖÐ369ÈË£¨96.6%£©Êµ¼ÊÍê³ÉÁ˼ì²â¡£328ÈË£¨88.9%£©±íʾÔÚ³öÏÖCOVID-19֢״ʱԸÒâÔÙ´ÎʹÓøÃ×ÔÎÒ¼ì²â¹¤¾ß£¬332ÈË£¨90%£©Í¬Ò⽫Æä×÷ΪCOVID-19ÃÜÇнӴ¥Õßɸ²éÊֶΡ£¾Í³É±¾¶øÑÔ£¬ÓÉÓڸüì²â¹¤¾ßÒ×ÓÚ»ñÈ¡¡¢Ê¹Óñã½ÝÇÒ³ö½á¹û¿ì£¬ÊÜ·ÃÕßÈÏΪÆäÊÇÒ»ÖÖ¿ÉÐеķ½°¸¡£ÒªÊµÏÖ×ÔÎÒ¼ì²âµÄ¹ã·ºÓ¦Óã¬ÐèÒªÌṩµ±µØÓïÑÔÖÆ×÷µÄ²Ù×÷Ö¸µ¼ÊÓÆµ£¬ÇÒÍÆ¹ã¹¤×÷Ӧͨ¹ýÉçÇøÇþµÀ¿ªÕ¹¡£ËùÓмල¼ì²âµÄÒ½»¤ÈËÔ±¶¼ÈÏΪ£¬×ÔÎÒ¼ì²âÊÇÌáÉý¼ì²â¿É¼°ÐÔ¡¢ÊµÏÖÔçÆÚÕï¶Ï¡¢¼õÉÙÒ½ÁÆ»ú¹¹Óµ¼·×´¿öÒÔ¼°½µµÍCOVID-19¸ÐȾ·çÏÕµÄÖØÒª¹¤¾ß¡£

½áÂÛ

Ö»ÒªÄÜÌṩ·ûºÏµ±µØÓïÑÔºÍÎÄ»¯ÌصãµÄ½¡¿µ½ÌÓýÄÚÈݼ°²Ù×÷Ö¸ÄÏ£¬ÇÒ¼Û¸ñºÏÀí£¬COVID-19×ÔÎÒ¼ì²â¾ÍÊÇÒ»ÖּȿɽÓÊÜÓÖ¿ÉÐеķ½°¸¡£Ó¦¿ª·¢ÊÊÓÃÓÚÏÖÓлòδÀ´¸÷ÀഫȾ²¡¼°ÆäËû·Ç´«È¾ÐÔ¼²²¡×ÔÎÒ¼ì²âµÄ¹¤¾ß°üÓëÅäÌ×ϵͳ¡£

±³¾°

ÔÚµÍÊÕÈëºÍÖеÈÊÕÈë¹ú¼Ò£¬COVID-19×ÔÎÒ¼ì²âÊÇÓÃÓÚÏÖ³¡¼ì²â¼°ÒßÇé¹ÜÀíµÄÖØÒª²ßÂÔ£¬ÓÐÖúÓÚʶ±ð¸ÐȾSARS-CoV-2µÄÈË¡£ÎÒÃÇÑо¿ÁËÔÚĪɣ±È¿ËÄϲ¿³ÇÊм°³Ç½¼µØÇø¡¢Õë¶ÔCOVID-19ºÍ½áºË²¡µÄÉçÇøË«Ïòɸ²éµãÉÏ£¬ÓÉÒ½»¤ÈËÔ±¼à¶½ÏµÄCOVID-19×ÔÎÒ¼ì²âµÄ¿ÉÐÐÐԺͿɽÓÊÜÐÔ¡£

·½·¨

2023Äê5ÔÂÖÁ8ÔÂÆÚ¼ä£¬³öÏÖCOVID-19ÒÉËÆÖ¢×´µÄÈËȺÒÔ¼°ÓиÐȾ·çÏÕµÄÈËȺ¿É½øÐÐ×ÔÎÒ¼ì²â¡£ÎÒÃÇÊÕ¼¯ÁËÕâЩÍê³É×ÔÎÒ¼ì²âÕßµÄÏà¹Ø»¤ÀíÁ÷³ÌÊý¾ÝÓëµ÷²éÊý¾Ý£¬²¢Í¨¹ýÂß¼­»Ø¹é·ÖÎöÓ°ÏìËûÃÇÔÙ´ÎʹÓøÃ×ÔÎÒ¼ì²â¹¤¾ßµÄ¿ÉÄÜÐÔµÄÒòËØ¡£´ËÍ⣬ÎÒÃÇ»¹¶Ô²¿·Ö¼ì²âÕß¼°¼à¶½ËûÃǵÄÒ½»¤ÈËÔ±½øÐÐÁ˰ë½á¹¹»¯Éî¶È·Ã̸£¬½ø¶øÔËÓÃÖ÷Ìâ·ÖÎö·¨¶ÔÆä·Ã̸¼Ç¼½øÐнâ¶Á¡£

½á¹û

ÎÒÃǹ²ÑûÇë382È˽øÐÐ×ÔÎÒ¼ì²â£¬ÆäÖÐ369ÈË£¨96.6%£©Êµ¼ÊÍê³ÉÁ˼ì²â¡£328ÈË£¨88.9%£©±íʾÔÚ³öÏÖCOVID-19֢״ʱԸÒâÔÙ´ÎʹÓøÃ×ÔÎÒ¼ì²â¹¤¾ß£¬332ÈË£¨90%£©Í¬Ò⽫Æä×÷ΪCOVID-19ÃÜÇнӴ¥Õßɸ²éÊֶΡ£¾Í³É±¾¶øÑÔ£¬ÓÉÓڸüì²â¹¤¾ßÒ×ÓÚ»ñÈ¡¡¢Ê¹Óñã½ÝÇÒ³ö½á¹û¿ì£¬ÊÜ·ÃÕßÈÏΪÆäÊÇÒ»ÖÖ¿ÉÐеķ½°¸¡£ÒªÊµÏÖ×ÔÎÒ¼ì²âµÄ¹ã·ºÓ¦Óã¬ÐèÒªÌṩµ±µØÓïÑÔÖÆ×÷µÄ²Ù×÷Ö¸µ¼ÊÓÆµ£¬ÇÒÍÆ¹ã¹¤×÷Ӧͨ¹ýÉçÇøÇþµÀ¿ªÕ¹¡£ËùÓмල¼ì²âµÄÒ½»¤ÈËÔ±¶¼ÈÏΪ£¬×ÔÎÒ¼ì²âÊÇÌáÉý¼ì²â¿É¼°ÐÔ¡¢ÊµÏÖÔçÆÚÕï¶Ï¡¢¼õÉÙÒ½ÁÆ»ú¹¹Óµ¼·×´¿öÒÔ¼°½µµÍCOVID-19¸ÐȾ·çÏÕµÄÖØÒª¹¤¾ß¡£

½áÂÛ

Ö»ÒªÄÜÌṩ·ûºÏµ±µØÓïÑÔºÍÎÄ»¯ÌصãµÄ½¡¿µ½ÌÓýÄÚÈݼ°²Ù×÷Ö¸ÄÏ£¬ÇÒ¼Û¸ñºÏÀí£¬COVID-19×ÔÎÒ¼ì²â¾ÍÊÇÒ»ÖּȿɽÓÊÜÓÖ¿ÉÐеķ½°¸¡£Ó¦¿ª·¢ÊÊÓÃÓÚÏÖÓлòδÀ´¸÷ÀഫȾ²¡¼°ÆäËû·Ç´«È¾ÐÔ¼²²¡×ÔÎÒ¼ì²âµÄ¹¤¾ß°üÓëÅäÌ×ϵͳ¡£

Ïà¹ØÐÂÎÅ
ÉúÎïͨ΢ÐŹ«ÖÚºÅ
ÉúÎïͨÐÂÀË΢²©
΢ÐÅ
ÐÂÀË΢²©
ÎÒҪͶ¸å
  • ËÑË÷
  • ¹ú¼Ê
  • ¹úÄÚ
  • ÈËÎï
  • ²úÒµ
  • Èȵã
  • ¿ÆÆÕ

ÈÈËÑ£ºÕªÒª|ÕªÒª|ÕªÒª|ÕªÒª|ÕªÒª

ÈȵãÅÅÐÐ

    ½ñÈÕ¶¯Ì¬ | È˲ÅÊг¡ | м¼ÊõרÀ¸ | Öйú¿ÆÑ§ÈË | ÔÆÕ¹Ì¨ | BioHot | ÔÆ½²ÌÃÖ±²¥ | »áÕ¹ÖÐÐÄ | ÌØ¼ÛרÀ¸ | ¼¼Êõ¿ìѶ | Ãâ·ÑÊÔÓÃ

    °æÈ¨ËùÓÐ ÉúÎïͨ

    Copyright© eBiotrade.com, All Rights Reserved

    ÁªÏµÐÅÏ䣺

    ÔÁICP±¸09063491ºÅ